Skip to content

Evonik Industries
Search Search

Skip over generic navigation

  • www.evonik.com

Skip over primary navigation

EUDRAGIT® | HOMEEUDRAGIT® | HOME
  • About EUDRAGIT®About EUDRAGIT®
  • Products & servicesProducts & services
  • Workshops & eventsWorkshops & events
  • DownloadsDownloads
  • e-Labe-Lab
  • ContactContact

Skip over visual

Skip over functional column

Skip over functional column

EUDRAGIT® - Functional polymers for protective, enteric and sustained-release formulations

  • Downloads
  • Scientific posters

Scientific Posters published by Evonik

APV 2012
PosterFormat
Development of storage stable, sustained release coatings based on EUDRAGIT® NM 30 DPDF
Scale-up of in-process cured sustained release coatings with EUDRAGIT® RS 30 DPDF

 

AAPS 2011
PosterFormat
Enteric Protection for Multi-particulates Using EUDRAGIT® L 100 and EUDRAGIT® S 100 Polymers in a Novel Rotor Granulation Dry Coating ProcessPDF
Exploring EUDRAGIT® E PO for Taste Masking of Bitter Drugs Using Hot Melt ExtrusionPDF
Prediction of API Solubility in Solid Solutions Using Modified Solubility Parameters, Film Casting and Melt ExtrusionPDF
Processing Ease Achieved with the Addition of Additives, in EUDRAGIT® NM 30 D for Top Spray Matrix GranulationsPDF
Storage Stable, In-process Cured Sustained Release Coatings Based on EUDRAGIT® NM 30 DPDF

 

CRS 2011
PosterFormat
Bioavailability Enhancement of Antiretrovirals via Melt Extrusion Using EUDRAGIT® PolymersPDF
Evaluation of EUDRAGIT® NE 40 D for Matrix Granulation ProcessesPDF
Rheological Characterization of (Meth)acrylic Copolymers Suitable for Melt Extrusion ApplicationsPDF
Taste Masking and Solubility Enhancement for Ibuprofen with EUDRAGIT® E PO by Spray DryingPDF

 

AAPS 2010
PosterFormat
A Systematic and Predictive Approach for Formulation Development of Poorly Soluble Drugs via Solid DispersionPDF
Evaluation of the Cleaning Efficacy of Insoluble EUDRAGIT® Polymers from Manufacturing Devices Using Different DetergentsPDF
Increased Film Flexibility for Enteric Multiparticulate Tablets with EUDRAGIT® Polymer CombinationsPDF
Novel Rotor-Granulator Powder Layering Process to Obtain Sustained Release Pellets with EUDRAGIT® RS POPDF
Scale-up of the Melt Extrusion Process Using EUDRAGIT® Polymers Containing Nifedipine as a Model Drug for Solubility EnhancementPDF
2010 (AAPS): The Effect of Anti-Adherent Agents on the Operational Efficiency of EUDRAGIT® L 30 D-55 CoatingPDF

 

APV 2010
PosterFormat
Scale-Up Study of Propranolol Sustained Release Pellets Coated with EUDRAGIT® NE 30 DPDF

 

CRS 2010
PosterFormat
PlasACRYL™ T20 as a Substitute for Glycerolmonostearate (GMS) for Coating Applications Using EUDRAGIT® L 30 D-55PDF
Scale-Up Study of Metoprolole Succinate Matrix Tablets Using EUDRAGIT® RS 30 DPDF

 

AAPS 2009
PosterFormat
Comparison of Moisture Protective Film Coatings on Hydrochlorothiazide TabletsPDF
Detection of Curing via NIR Shown for EUDRAGIT® RL/RS 30 DPDF
Effect of Curing and Storage Conditions on Drug Release from Multi-Particulates Coated with EUDRAGIT® L 100PDF
pH Independent Sustained Release Matrix Formulation with EUDRAGIT® FS 30 DPDF
Release Modifying Potential EUDRAGIT® RS, RL, EUDRAGIT® NE 30 D in Multi-Particulate SystemsPDF
Sustained Release Matrix Formulation with EUDRAGIT® NM 30 D for Soluble DrugsPDF
Utilization Novel Rotor-Granulator Powder Layering Technique to Taste Mask Acetaminophen Pellets with EUDRAGIT® E POPDF

 

CRS 2009
PosterFormat
Correlation of In Vitro and In Vivo Release of EUDRAGIT® NE 30 D Coated Venlafaxine PelletsPDF
Effect of Different Post Coating Drying Conditions and Low Storage Temperatures on Drug Release from EUDRAGIT® L 30 D-55 Coated Multi-ParticulatesPDF
Melt Extruded Modified Release Micropellets Using PolymethacrylatesPDF
Taste Masked Ondansetron Orally Disintegrating Formulations with EUDRAGIT® PolymersPDF

 

AAPS 2008
PosterFormat
Controlled release of Tamsulosin hydrochloride using EUDRAGIT® polymersPDF
Strategies to Accelerate Drug Release at Lower pH-Values from Dosage Forms Coated with EUDRAGIT® L 30 D-55PDF
Effect of Different Storage Conditions on Drug Release from Multi-Particulates Coated with EUDRAGIT® FS 30 DPDF
EUDRAGIT® Coated Sustained Release Venlafaxine Multiparticulate FormulationsPDF

 

APV 2008
PosterFormat
Improved Curing of EUDRAGIT® RL/RS 30 D Film Coatings by Controlled In-Process Curing in the Fluid BedPDF
Stoichometry of Complexes Formed Between EUDRAGIT® E PO and EUDRAGIT® L 100-55PDF

 

CRS 2008
PosterFormat
Accurate GI Targeting with EUDRAGIT® FS 30 D or L 30 D-55 MixturesPDF
Controlled Release Formulation of Tamsulosin HCl using EUDRAMODE TechnologyPDF
Melt Extrusion Processes with EUDRAGIT® Polymers for Heat-Sensitive Substances like ProteinsPDF
Organoleptically Appealing Immediate Release EUDRAGIT® CoatingsPDF

 

 

Overview

Business model
News

Overview

EUDRAGIT® products
  • Enteric formulations
    • EUDRAGIT® L 30 D-55
    • EUDRAGIT® L 100-55
    • EUDRAGIT® L 100
    • EUDRAGIT® L 12,5
    • EUDRAGIT® S 100
    • EUDRAGIT® S 12,5
    • EUDRAGIT® FS 30 D
  • Protective formulations
    • EUDRAGIT® E 100
    • EUDRAGIT® E 12,5
    • EUDRAGIT® E PO
  • Sustained-release formulations
    • EUDRAGIT® RL 100
    • EUDRAGIT® RL PO
    • EUDRAGIT® RL 30 D
    • EUDRAGIT® RL 12,5
    • EUDRAGIT® RS 100
    • EUDRAGIT® RS PO
    • EUDRAGIT® RS 30 D
    • EUDRAGIT® RS 12,5
    • EUDRAGIT® NE 30 D
    • EUDRAGIT® NE 40 D
    • EUDRAGIT® NM 30 D
  • PlasACRYL™ T20
Technical support
  • Laboratories worldwide
    • Laboratories in China
    • Laboratories in Germany
    • Laboratories in India
    • Laboratories in Japan
    • Laboratories in the USA
Formulation development
GMP services
  • GMP facilities in Germany
Proof of concept
Advanced drug delivery

Overview

Workshops
Trade shows
Webinars

Overview

Pharma Polymers News
EUDRAGIT® Quickstarts
Brochures
Scientific posters
Product specifications
Other downloads

Overview

Open the e-Lab
What is the e-Lab?
 
  • Contact
  • Sitemap
  • Company information
  • Legal notice
  • Privacy policy
  • Print
  • Send this page